Literature DB >> 863632

Long term follow-up of transcatheter embolization with autologous clot, oxycel and gelfoam in domestic swine.

K H Barth, J D Strandberg, R I White.   

Abstract

Transcatheter embolization of the distal gastrosplenic artery as well as the distal right renal artery or one of its bifurcational branches was performed in 9 domestic swine. The animals were embolized with fresh autologous clot, oxycel or gelfoam in groups of 3. The embolic material was opacified with tantalum in several animals. At 4 months, none of the initial occlusions was sustained and recanalization without residuals was found in the left gastroepipolic artery with only one minor exception. Organized thrombi as sole vascular residuals regardless of embolic substance were found in both the terminal splenic artery as well as in the right renal artery distribution in various degrees together with infarcts in both organs. No trace of either oxycel or gelfoam remained, nor tissue reaction against either material. All 3 agents are therefore regarded equivalent in their long term effects and are not suitable for permanent vascular occlusion.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 863632     DOI: 10.1097/00004424-197705000-00012

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  16 in total

1.  Pharmaceuticals for Intra-arterial Therapy.

Authors:  Aalpen A Patel; Jeffery A Solomon; Michael C Soulen
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

Review 2.  Current status of embolic agents for liver tumor embolization.

Authors:  Keigo Osuga; Noboru Maeda; Hiroki Higashihara; Shinichi Hori; Tetsuro Nakazawa; Kaishu Tanaka; Masahisa Nakamura; Kentaro Kishimoto; Yusuke Ono; Noriyuki Tomiyama
Journal:  Int J Clin Oncol       Date:  2012-07-18       Impact factor: 3.402

3.  Calibrated Bioresorbable Microspheres as an Embolic Agent: An Experimental Study in a Rabbit Renal Model.

Authors:  Lihui Weng; Davis Seelig; Parinaz Rostamzadeh; Jafar Golzarian
Journal:  J Vasc Interv Radiol       Date:  2015-03-29       Impact factor: 3.464

4.  Therapeutic embolization with detachable balloons.

Authors:  R I White; K H Barth; S L Kaufman; V DeCaprio; J D Strandberg
Journal:  Cardiovasc Intervent Radiol       Date:  1980       Impact factor: 2.740

5.  Intraarterial ethanol as a long-term occlusive agent in renal, hepatic, and gastrosplenic arteries of pigs.

Authors:  R F Latshaw; R L Pearlman; B M Schaitkin; J W Griffith; W A Weidner
Journal:  Cardiovasc Intervent Radiol       Date:  1985       Impact factor: 2.740

Review 6.  Transcatheter vessel occlusion: selection of methods and materials.

Authors:  A J Greenfield
Journal:  Cardiovasc Intervent Radiol       Date:  1980       Impact factor: 2.740

7.  Transcatheter obliteration of the renal artery by ethanol injection: experimental results.

Authors:  L Ekelund; N Jonsson; H Treugut
Journal:  Cardiovasc Intervent Radiol       Date:  1981       Impact factor: 2.740

8.  Temporary embolization in urological practice: myth or reality?

Authors:  G Carmignani; E Belgrano; P Puppo; U Repetto; L Giuliani
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

9.  Partial splenic embolisation using n-butyl cyanoacrylate: intraprocedural evaluation by magnetic resonance imaging.

Authors:  Jun Koizumi; Chihiro Itou; Rick Wray; Kazunori Myojin; Takeshi Hashimoto; Yoshimi Nagata; Hiroshi Yamamuro; Tomoatsu Tsuji; Tamaki Ichikawa; Kouichi Shiraishi; Tatehiro Kagawa; Tetsuya Mine; Norihito Watanabe; Mitsunori Matsumae; Bertrand Janne d'Othée
Journal:  Eur Radiol       Date:  2012-11-19       Impact factor: 5.315

10.  Percutaneous trans-hepatic gelfoam-cyanoacrylate glue embolization for ruptured post-traumatic hepatic artery pseudo-aneurysm in a limited-resource scenario.

Authors:  Manoj Kumar; Prabudh Goel; J D Rawat; Shweta Kumari; S N Shankhwar; S N Kureel
Journal:  Pediatr Surg Int       Date:  2013-03-12       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.